Unknown NA INTERVENTIONAL 4-arm NCT05495672

Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules

Circulating Tumor DNA Guided Therapeutic Strategies for Colorectal Cancer Patients With Small Pulmonary Nodules Suspected to be Metastases: an Open-Label, Prospective, Phase II Cohort Study

Sponsor: Junjie Peng

Conditions Advanced Colorectal Cancer Circulating Tumor DNA

Interventions Local treatment

Updated 4 times since 2022 Last updated: Aug 8, 2022 Started: Aug 1, 2022 Primary completion: Dec 1, 2023 Completion: Dec 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05495672, this NA trial focuses on Advanced Colorectal Cancer and Circulating Tumor DNA and remains ongoing. Sponsored by Junjie Peng, it has been updated 4 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Recruiting NA

First recorded

Aug 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Junjie Peng
Shanghai OrigiMed Co., Ltd.

Data source: Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China